Literature DB >> 14629653

The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.

Jeong-Seon Ryu1, Hun-Jae Lee, Jae-Hwa Cho, Hye-Seung Han, Hong-Lyeol Lee.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the false positive rate for pleural fluid carcinoembryonic antigen (CEA) level in non-malignant pleural effusions and to determine whether the falsely elevated CEA level has any relation to other biochemical parameters of pleural effusions.
METHODOLOGY: We performed a retrospective analysis of 654 consecutive patients with a pleural effusion admitted to the pulmonary department of a tertiary referral teaching hospital from March 1997 to March 1999. The aetiology of the pleural effusions were classified as tuberculosis (n = 262), malignancy (n = 204), pneumonia (n = 145), exudates of other origin (n = 28) and transudate (n = 1).
RESULTS: A false positive result for pleural fluid CEA level (> 5 ng/mL) was registered in 13.8% of non-malignant pleural effusion cases: empyema (38.6%), parapneumonic effusion (14.7%), exudates of other origin (14.3%), tuberculosis (7.3%) and transudate (6.7%). In analysis of the subgroup with false positive results for pleural fluid CEA level, the CEA level of non-malignant pleural effusion showed a significant relationship to the severity of pleural inflammation in terms of the following variables: LDH (rs = 0.4201, P= 0.001), adenosine deaminase (ADA) (rs = 0.4440, P= 0.0004), white blood cell count (rs = 0.4266, P= 0.0004), polymorphonuclear cell percentage (rs = 0.5080, P= 0.0001), and polymorphonuclear cell count (rs = 0.5095, P= 0.0002). In the parapneumonic effusion and empyema groups, the changes in pleural fluid CEA level exhibited a positive association with the changes in the pleural fluid ADA level (rs = 0.8143, P= 0.0002).
CONCLUSIONS: The results from our series indicated that false positive results for pleural fluid CEA level were most commonly observed in patients with empyema and parapneumonic effusion and the CEA level showed a significant correlation to the indices of pleural inflammation. The serial measurement of pleural fluid CEA level may be useful as a means of monitoring resolution of pleural inflammation and excluding the possibility of a malignant pleural effusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629653     DOI: 10.1046/j.1440-1843.2003.00502.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.

Authors:  Sied Mohammad Ali Ghayumi; Samrad Mehrabi; Mehrnossh Doroudchi; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

2.  Proteomic study of benign and malignant pleural effusion.

Authors:  Hongqing Li; Zhonghao Tang; Huili Zhu; Haiyan Ge; Shilei Cui; Weiping Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-05       Impact factor: 4.553

3.  Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.

Authors:  Jaume Trapé; Francesc Sant; Josefina Franquesa; Jesús Montesinos; Anna Arnau; Maria Sala; Oscar Bernadich; Esperanza Martín; Damià Perich; Concha Pérez; Joan Lopez; Sandra Ros; Enrique Esteve; Rafael Pérez; Jordi Aligué; Gabriel Gurt; Silvia Catot; Montserrat Domenech; Joan Bosch; Josep Miquel Badal; Mariona Bonet; Rafael Molina; Josep Ordeig
Journal:  Respir Res       Date:  2017-05-25

4.  Combination of procalcitonin, C-reaction protein and carcinoembryonic antigens for discriminating between benign and malignant pleural effusions.

Authors:  Mingde Ji; Xiaofei Zhu; Jie Dong; Shining Qian; Fei Meng; Wanjian Gu; Wen Qiu
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

5.  Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.

Authors:  Jaehee Lee; Ji Eun Park; Sun Ha Choi; Hyewon Seo; Sang Yub Lee; Jae Kwang Lim; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Chang Ho Kim
Journal:  Korean J Intern Med       Date:  2021-07-15       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.